Vivace Therapeutics rallies $30m Series C
Vivace Therapeutics, Inc, a small molecule discovery and development company, has secured $30 million in Series C financing.
Vivace Therapeutics, Inc, a small molecule discovery and development company, has secured $30 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination